PHARMACEUTICAL FORMULATIONS

This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PATEL, MANISH, MATHUR, ANOOP, DUTT, CHAITANYA, CHAUDHARI, ANITA, DESHPANDE, SHAILESH, LATAD, SACHIN, MISHRA, VIVEK, ZAMBAD, SHITAL, KUMAR, KOTECHA, JIGNESH, GUPTA, RAMESH, CHANDRA, ABRAHAM, JAYA, KESARWANI, AMIT
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.